Summary & Overview
HCPCS G2124: Frailty with Dispensed Dementia Medication, Ages 66–80
HCPCS Level II code G2124 identifies patients aged 66–80 who had at least one documented encounter for frailty during the measurement period and who received a dispensed dementia medication. As a clinical measurement code, it links geriatric frailty assessment with active dementia pharmacotherapy, informing quality monitoring and care coordination efforts across outpatient and pharmacy settings. Nationally, this code matters because it highlights a vulnerable cohort at risk for adverse outcomes and may be used in payer quality programs and value-based arrangements to track appropriate care for older adults with cognitive impairment.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context of the code, common places of service where encounters and dispensing occur, and the implications for quality measurement and care management. The publication also summarizes what is known about typical usage and reporting considerations and flags where input data were not available. This overview equips policy analysts, payers, and health system leaders with a clear starting point for assessing how G2124 fits into geriatric care pathways and payer reporting workflows.
Billing Code Overview
HCPCS Level II code G2124 captures patients aged 66–80 years who had at least one claim or encounter documenting frailty during the measurement period and a dispensed dementia medication. This code denotes a combined clinical status measure linking identification of frailty with active pharmacologic treatment for dementia.
-
Service type: Measurement/quality reporting tied to geriatric care and medication dispensing
-
Typical site of service: Ambulatory outpatient settings, primary care clinics, memory care clinics, and pharmacy-dispensing environments
Clinical & Coding Specifications
Clinical Context
A typical patient is an ambulatory 72-year-old Medicare beneficiary with a documented frailty diagnosis who fills a dispensed dementia medication during the measurement period. The patient presents to a primary care clinic or geriatric specialty practice for routine follow-up of cognitive decline and functional status. The clinical workflow begins with a nursing triage that documents weight loss, slow gait, or fatigue prompting a frailty screening using validated tools (for example, gait speed or the Clinical Frailty Scale). The provider reviews medication adherence and confirms an active prescription for a dementia medication (such as donepezil or memantine) that has been dispensed by the pharmacy during the measurement period. Relevant documentation includes the frailty encounter note, the problem list with a frailty- related ICD-10 code, medication reconciliation showing the dispensed dementia drug, and the date(s) of service within the measurement period. Typical sites of service are outpatient primary care clinics, geriatric clinics, family medicine offices, and home-based primary care visits where frailty assessment and medication reconciliation occur. Modifiers from the provided list are applied as clinically appropriate for billing adjustments (for example, for services with increased complexity, unusual anesthesia circumstances, or split/shared services).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased Procedural Services | Use when the service required substantially greater effort or complexity than usual and documentation supports additional work. |